AbelZeta Inc.

Model C-CAR168 - Inflammatory & Immunological Diseases

SHARE

PRODUCT: C-CAR168. INDICATION: Autoimmune. PLATFORM: CAR-T. PRECLINICAL: CD20 / BCMA. IIT: -. PHASE 1/1B: -. PHASE 2: -. PARTNERS: -